🇺🇸 Ropivacaine and Dexmedetomidine in United States

Ropivacaine and Dexmedetomidine (Ropivacaine and Dexmedetomidine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Ropivacaine and Dexmedetomidine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ropivacaine and Dexmedetomidine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ropivacaine and Dexmedetomidine in United States?

B.P. Koirala Institute of Health Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.